Related Experiment Videos
Pump infusion of pilocarpine
Summary
New pilocarpine delivery via the Sage Model 216 pump significantly enhanced glaucoma treatment. This method doubled the ocular hypotensive effect and prolonged its duration, offering a more effective glaucoma management option.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Current treatments like pilocarpine eye drops have limitations in efficacy and duration.
Purpose of the Study:
- To evaluate the efficacy and safety of continuous pilocarpine infusion for glaucoma management.
- To compare the ocular hypotensive effect of continuous infusion versus standard eye drops.
Main Methods:
- Pilocarpine was infused into the conjunctival sac of glaucoma patients using the Sage Model 216 pump.
- Doses up to 20 mg were administered over 30 minutes.
- Ocular pressure was monitored to assess hypotensive effects and duration.
Main Results:
- Continuous pilocarpine infusion showed no ocular or systemic toxicity, even at high doses (20 mg).
- The ocular hypotensive effect was doubled compared to standard pilocarpine eye drops (4% given four times daily).
- The duration of the ocular hypotensive effect was markedly prolonged, with pressure returning to baseline in an average of 33.9 hours after a single 20 mg infusion.
Conclusions:
- Continuous pilocarpine infusion via the Sage Model 216 pump offers a safe and more effective alternative for glaucoma treatment.
- This delivery method provides enhanced efficacy and significantly prolonged duration of action compared to conventional eye drops.
- Further research into sustained drug delivery systems is warranted for improved glaucoma patient outcomes.